BOAI NKY MEDICAL HOLDINGS LTD.

Eighteen years of qualification Audited Supplier

Eighteen years of qualification Audited Supplier

Company Profile
  • Year Established: 1987
  • Total Assets(USD): 35,000,000 To 39,999,999
  • Total Number of Staff: 450 to 499
  • Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Business Type: Manufacturer
  • R&D Capacity: Own brand
  • Annual Turnover(USD) : 35,000,000 To 39,999,999
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

THE COMPANY Publically traded company on the Shenzhen stock exchange (stock code 300109) First domestic company to develop and manufacture PVP and PVM/MA products 3rd Largest Global PVP manufacturer 2nd Largest Global PVM/MA manufacturer International offices in China, Europe and Japan Global distribution network   OUR PRODUCTS 12,000 MT/year of PVP capacity 2,500 MT/year of PVM/MA capacity 12,000 MT/year GBL, 2-pyrrolidone and NVP 2,500 MT/year vinyl ethers   QUALITY First Chinese manufacturer to be EXCiPACTTM GMP certified All pharmaceutical products manufactured under strict cGMP guidelines All pharma products handled and packaged in class D cleanrooms State of the art manufacturing facility (commissioned 2013) QC equipment and test methods fully validated and fully audit trail compliant   ENVIRONMENTAL RESPONSIBILITY Fully compliant with government requirements and regulations Real time monitoring of waste streams 100% recycling of processing water Complete conversion from coal to natural gas Focus on developing green production processes   CUSTOMER and TECHNICAL SERVICE Technical Research Center to assist our customer with formulation development New R&D center commissioned in 2018 having integrated R&D and pilot manufacturing Customer partnering to develop new opportunities Strong customer and quality management services to assist our customers   NKY® is the registered trademark of Boai NKY Pharmaceuticals Ltd (NKY). KoVidone®, PolyKoVidone® and, OraRez® are the trademark names of NKY.

Year Established: 1987

Total Assets(USD): 35,000,000 To 39,999,999

Total Number of Staff: 450 to 499

Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Business Type: Manufacturer

R&D Capacity: Own brand

Annual Turnover(USD) : 35,000,000 To 39,999,999

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Top Products
Copyright 2006-2020 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by